IL1B and type 2 diabetes mellitus: In addition, western blot analysis revealed that proinflammatory markers NF-κB, IL-1β, and IL-6 were significantly elevated in the T2DM group but were markedly suppressed following sitagliptin treatment (Figures 5c, d).